IRCT20100606004105N30 IRCT 2020-08-02 Tabriz University of Medical Sciences Effect of zinc in treatment of Behcet syndrome The effects of zinc gluconate supplementation on several genes expression, the serum level of inflammatory factors, quality of life, and disease activity in patients with Behcet syndrome: double-blind randomized controlled clinical trial 2020-08-22 anticipated 52 Complete https://irct.ir/trial/49785 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: After reaching the inclusion criteria, individuals will be randomly divided into two groups of intervention and placebo by blocking method. Blocking will be performed based on gender and age and whereby the two groups will be matched in terms of age and gender. The four blocks will be created by STATA statistical software using ralloc command, which will be identified by the letters A, B, C, D. The assigned group is not known before the individual assignment, Blinding description: All tablets (zinc and placebo) in the same shape and color are placed and labeled in the containers by a third person, and two codes are given to individuals, and the codes will be unknown to the researcher until the end of the study. 2-3 Behcet Syndrome. Intervention 1: Intervention group: one zinc gluconate tablet daily (120 mg each tablet containing 30 mg elemental zinc) with a meal for 12 weeks. Intervention 2: Control group: Placebo (microcrystalline cellulose): 1 tablet (120 mg each) with a meal for 12 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information